Scientific data shows that glyphosate (Roundup) has antibiotic properties and can preferentially inhibit beneficial microbial species while allowing pathogenic ones to persist or flourish.

1. Glyphosate’s Function as an Antibiotic
Glyphosate’s herbicidal action is due to its ability to inhibit the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) in the shikimate pathway.
Mechanism of Action: The shikimate pathway is essential for the bio-synthesis of three essential aromatic amino acids (tyrosine, tryptophan, and phenylalanine) in plants, fungi, and many species of gut bacteria. Since this pathway is absent in mammals, it was historically assumed to be non-toxic to humans.
Antimicrobial Patent: The antimicrobial activity of glyphosate is formally recognised. In 2010, Monsanto (the original producer of Roundup) was granted a patent (US7771736B2) for glyphosate as an antimicrobial agent for the treatment of pathogenic infections.
2. Preferential Killing of Healthy vs. Pathogenic Species:
Studies have demonstrated a differential susceptibility to glyphosate among different types of gut bacteria, which can lead to an imbalance, known as dysbiosis.

This differential effect means that glyphosate can effectively act as a selection agent, depleting the populations of beneficial bacteria that normally keep pathogens in check, thereby favouring the overgrowth of the more resistant pathogenic species.

Glyphosate is the largest selling products but the estimated total pesticides & herbicides market value (2024) is USD $70 Billion to $108 Billion.

This video as a summary, Antibiotics & Pesticides: Why They’re DESTROYING Your Gut Health!